Allergic Rhinitis Meds Expand with Newly Approval Dymista Nasal Spray
US Food and Drug Administration (FDA) approved Dymista a novel formulation of azelastine hydrochloride and fluticasone propionate, for the treatment of allergic rhinitis, by Swedish pharmaceutical company Meda Sweden. The nasal spray Dymista is indicated for the relief of symptoms of seasonal allergic rhinitis in patients over 12 years. Meda CEO Anders Lonner said, “Allergic [...]
